Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034308518> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W2034308518 endingPage "5" @default.
- W2034308518 startingPage "4" @default.
- W2034308518 abstract "Patent ductus arteriosus (PDA) is present in up to 75% of infants born before 28 weeks gestation, and issues concerning PDA remain a popular topic in neonatology. The large range of articles addressing the assessment and treatment of PDA demonstrates the continuing uncertainty regarding the best way to manage an infant with this complication of prematurity. PDA is associated with many of the adverse outcomes of prematurity; however, there are conflicting results on the benefits of PDA closure from the many randomised and observational studies targeting PDA treatment. Consequently, there are ongoing questions as to when to treat, what to treat, and how to treat. Complicating factors, such as efficacy, dosage issues, risk of side effects, and the large variation in cost of potential treatments are becoming increasingly important, as neonatologists try to optimize available therapies. Neonatology has a track record of introducing medications before the pharmacokinetics in our population are properly understood. Enteral or intravenous indomethacin was the mainstay of PDA treatment for many years, ever since its use was first described in 1976. More recently, ibuprofen, initially as an intravenous infusion, has been utilized and found to be of similar efficacy as intravenous indomethacin. There are, however, indications that the appropriate dose to maintain therapeutic ibuprofen levels is not being achieved with intravenous dosing, resulting in increased treatment failure rates. Oral medication, which is simple to administer and effective, with minimal side effects, would be likely to change the balance in favour of treatment in many preterm infants. In this issue of the Journal, Yang et al. describe their experience with the use of oral ibuprofen versus intravenous indomethacin in a group of extremely low birth weight infants. In this retrospective cohort study, oral ibuprofen syrup (10 mg/kg initial dose, followed by two doses of 5 mg/kg at 24-hour intervals) was found to be as efficacious as intravenous indomethacin. The closure rate on initial treatment was 81.8% for oral ibuprofen versus 88.5% for intravenous indomethacin (p = 0.40). Importantly, there were no differences in side effects or complications between the two approaches. These were small infants, all under 1,000 g, and treated on average at 5 days of age. Other studies have confirmed the high closure rates and favourable safety profile of oral ibuprofen. Most recently, Erdeve et al. performed a randomised controlled trial of oral versus intravenous ibuprofen in 80 preterm infants, and found a higher initial closure rate with oral ibuprofen, though there was a higher re-opening rate in infants who received this treatment. Interestingly, there was also a reduction in the incidence of chronic lung disease in the orally treated group. Other studies have" @default.
- W2034308518 created "2016-06-24" @default.
- W2034308518 creator A5050561290 @default.
- W2034308518 date "2013-01-01" @default.
- W2034308518 modified "2023-09-28" @default.
- W2034308518 title "Oral Ibuprofen and the Patent Ductus Arteriosus: A New Approach to an Old Problem" @default.
- W2034308518 cites W1985075053 @default.
- W2034308518 cites W1993156138 @default.
- W2034308518 cites W1993237414 @default.
- W2034308518 cites W2005646040 @default.
- W2034308518 cites W2006817615 @default.
- W2034308518 cites W2014811565 @default.
- W2034308518 cites W2018560295 @default.
- W2034308518 cites W2020896435 @default.
- W2034308518 cites W2057466226 @default.
- W2034308518 cites W2100463689 @default.
- W2034308518 cites W2104667033 @default.
- W2034308518 cites W2156517806 @default.
- W2034308518 doi "https://doi.org/10.1016/j.jped.2013.02.002" @default.
- W2034308518 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23544804" @default.
- W2034308518 hasPublicationYear "2013" @default.
- W2034308518 type Work @default.
- W2034308518 sameAs 2034308518 @default.
- W2034308518 citedByCount "3" @default.
- W2034308518 countsByYear W20343085182014 @default.
- W2034308518 countsByYear W20343085182015 @default.
- W2034308518 countsByYear W20343085182023 @default.
- W2034308518 crossrefType "journal-article" @default.
- W2034308518 hasAuthorship W2034308518A5050561290 @default.
- W2034308518 hasBestOaLocation W20343085181 @default.
- W2034308518 hasConcept C164705383 @default.
- W2034308518 hasConcept C177713679 @default.
- W2034308518 hasConcept C2779944601 @default.
- W2034308518 hasConcept C2781236024 @default.
- W2034308518 hasConcept C71924100 @default.
- W2034308518 hasConcept C98274493 @default.
- W2034308518 hasConceptScore W2034308518C164705383 @default.
- W2034308518 hasConceptScore W2034308518C177713679 @default.
- W2034308518 hasConceptScore W2034308518C2779944601 @default.
- W2034308518 hasConceptScore W2034308518C2781236024 @default.
- W2034308518 hasConceptScore W2034308518C71924100 @default.
- W2034308518 hasConceptScore W2034308518C98274493 @default.
- W2034308518 hasIssue "1" @default.
- W2034308518 hasLocation W20343085181 @default.
- W2034308518 hasLocation W20343085182 @default.
- W2034308518 hasLocation W20343085183 @default.
- W2034308518 hasOpenAccess W2034308518 @default.
- W2034308518 hasPrimaryLocation W20343085181 @default.
- W2034308518 hasRelatedWork W177019059 @default.
- W2034308518 hasRelatedWork W2001431596 @default.
- W2034308518 hasRelatedWork W2368829227 @default.
- W2034308518 hasRelatedWork W2414428146 @default.
- W2034308518 hasRelatedWork W2425016358 @default.
- W2034308518 hasRelatedWork W2530816000 @default.
- W2034308518 hasRelatedWork W2730212004 @default.
- W2034308518 hasRelatedWork W3030284760 @default.
- W2034308518 hasRelatedWork W3087597853 @default.
- W2034308518 hasRelatedWork W37660807 @default.
- W2034308518 hasVolume "89" @default.
- W2034308518 isParatext "false" @default.
- W2034308518 isRetracted "false" @default.
- W2034308518 magId "2034308518" @default.
- W2034308518 workType "article" @default.